Guardant files for NASDAQ IPO

Guardant Health Inc. (Redwood City, Calif.) filed on Sept. 6 to raise up to $100 million in an IPO on NASDAQ underwritten by J.P. Morgan, BofA Merrill Lynch, Cowen, Leerink and William Blair.

The liquid biopsy company’s last venture round came in May 2017, when it raised $360 million in a series E led by Softbank, which holds a 39% stake in the biotech. Sequoia Capital and Khosla Ventures hold 11% and 10.1%, respectively...